What is it about?

Review on the current standard of care systemic treatments options, ongoing investigational trials, and future directions for advanced bladder cancer

Featured Image

Read the Original

This page is a summary of: Systemic treatments for metastatic urothelial carcinoma, Expert Opinion on Pharmacotherapy, November 2018, Taylor & Francis,
DOI: 10.1080/14656566.2018.1544242.
You can read the full text:

Read

Contributors

The following have contributed to this page